ML for drug discovery at Genesis Therapeutics

Host

MIT CSAIL, AI@MIT Reading Group

RSVP here: https://forms.gle/V3YRySh1urjvCMSt5

 

Genesis Therapeutics is an industry-leading start-up in the ML-driven drug discovery space. At Genesis, we are integrating ML into many phases of the drug discovery process: from generating new molecules, to sampling protein-ligand conformations, to predicting properties such as potency and ADME. Genesis has built a state-of-the-art denoising diffusion model for protein-ligand structure prediction. Genesis has also developed ML models for molecular property prediction to accelerate the virtual screening process and de-risk drug discovery programs. Genesis Therapeutics has raised over $300M in funding from top technology and biotech investors. We are hiring for internship and full-time positions in ML research, software engineering, and computational chemistry at https://genesistherapeutics.ai/careers/